Who owns Valeant Pharmaceuticals Int?

Key details on Valeant Pharmaceuticals Int (Ticker: VRX)

Who owns Valeant Pharmaceuticals Int?

Is VRX a good stock to own? Find out who bought Valeant Pharmaceuticals Int, who sold Valeant Pharmaceuticals Int (VRX) stock, and who holds a large position in Valeant Pharmaceuticals Int.

Fund Name Number of Shares Share Valuation As Of
Ruane, Cunniff & Goldfarb 34.30M $4.33B June 30, 2014
ValueAct Holdings 18.92M $2.48B Sept. 30, 2014
T. Rowe Price Associates 16.46M $2.08B June 30, 2014
Lone Pine Capital 10.99M $1.44B Sept. 30, 2014
FMR 10.82M $1.42B Sept. 30, 2014
VIKING GLOBAL INVESTORS 9.97M $1.31B Sept. 30, 2014
Barclays 8.75M $1.15B March 31, 2014
BANK OF MONTREAL /CAN/ 7.54M $989.74M Sept. 30, 2014
Blue Ridge Capital Holdings 7.52M $279.13M Sept. 30, 2011
GOLDMAN SACHS 6.56M $306.42M Dec. 31, 2011
JPMORGAN CHASE & CO 6.20M $814.09M Sept. 30, 2014
Greystone Managed Investment 5.83M $311.84M March 31, 2012
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 5.69M $746.60M Sept. 30, 2014
Brave Warrior Advisors 5.59M $737.27M March 31, 2014
Toronto-Dominion Bank 5.48M $718.34M Sept. 30, 2014
Blue Ridge Capital 5.45M $254.46M Dec. 31, 2011
Loomis, Sayles and 4.69M $550.74M Dec. 31, 2013
Name Goodman & Company, Investment Counsel 4.62M $207.08M June 30, 2012
CIBC World Markets 4.62M $605.62M Sept. 30, 2014
Caisse de depot et placement du Quebec 4.57M $599.53M Sept. 30, 2014
Janus Capital Management 4.54M $391.19M June 30, 2013
Brave Warrior Capital 4.41M $236.94M March 31, 2012
Brahman Capital 4.36M $241.01M Sept. 30, 2012
MORGAN STANLEY 4.36M $574.15M March 31, 2014
Institutional Capital 4.32M $566.75M Sept. 30, 2014
Connor, Clark & Lunn Investment Management 4.25M $529.78M Dec. 31, 2013
Orbis Holdings 4.13M $355.51M June 30, 2013

Who sold Valeant Pharmaceuticals Int?

Fund Name Date Sold Number of Shares Sold Share Valuation
Norges Bank Investment Management Sept. 30, 2012 4.86M $255.76M
HARRIS FINANCIAL Sept. 30, 2011 5.69M $211.13M
Royal Bank of Canada Sept. 30, 2011 4.36M $161.66M
Iridian Asset Management Sept. 30, 2011 4.14M $153.62M
Nicholas Investments Partners June 30, 2011 4.40M $4.36M
Commerzbank Aktiengesellschaft Dec. 31, 2010 5.42M $153.32M
Osterweis Capital Management Dec. 31, 2010 4.82M $136.26M